Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus

Current Topics in Microbiology and Immunology

Volumn 269, Issue , 2002, Pages 101-115

  Johnson, D C ^a   Hegde, N R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; GLYCOPROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA D ANTIGEN; HLA DMB; HLA-DMB; IMMEDIATE EARLY PROTEIN; MEMBRANE PROTEIN; US3 PROTEIN, CYTOMEGALOVIRUS; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; COMPLEX FORMATION; CYTOMEGALOVIRUS; EPITHELIUM CELL; GENOME ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; VIRUS INHIBITION; VIRUS REACTIVATION; VIRUS REPLICATION; ANIMAL; CD4+ T LYMPHOCYTE; CYTOMEGALIC INCLUSION BODY DISEASE; IMMUNOLOGY; METABOLISM; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; VIROLOGY;

ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL TRANSPORT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMAN; IMMEDIATE-EARLY PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL PROTEINS; VIRUS REPLICATION; ANIMALS; HUMANS; MEMBRANE PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0035988044     PISSN: 0070217X     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-59421-2_7     Document Type: Article

References (57)

1. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
2. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAPI
3. Viral mechanisms of immune evasion
4. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments
5. Cytotoxic T cells and human herpes virus infections
6. Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation
7. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells
8. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins
9. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles
10. Assembly, transport, and function of MHC class II molecules
11. Invariant chain structure and MHC class II function
12. Evolution of recurrent herpes simplex virus lesions: An immunohistologic study
13. HLA-DM induces CLIP dissociation from MHC class II α/β dimers and facilitates peptide loading
14. Removal and degradation of the free MHC class II β chain in the endoplasmic reticulum required proteasomes and is accelerated by BFA
15. Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation of state of ser900
16. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway
17. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response
18. Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2
19. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner
20. Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen
21. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus
22. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing
23. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells
24. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells
25. The ER translocon and retrotranslocation: Is the shift into reverse manual or automatic?
26. Viral immune evasion
27. Multiple independent loci within the human cytomegalovirus unique short region down regulate expression of major histocompatibility complex class I heavy chains
28. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains
29. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins
30. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways
31. Effective formation of major histocompatibility complex class II-peptide complexes from endogenous antigen by thyroid epithelial cells
32. Processing pathways for presentation ofcytosolic antigen to MHC class II restricted T cells
33. The cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions
34. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
35. Human cytomegalovirus inhibits IFNα-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction
36. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNAI
37. CIIV, MIIC and other compartments for MHC class Il loading
38. Class II MHC molecules can use the endogenous pathway of antigen presentation
39. MHC class II-restricted antigen processing and presentation
40. Principles for adoptive T cell therapy of human viral diseases
41. Sequence analysis of peptides bound to MHC class II molecules
42. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: Characterization of a potential site of virus assembly
43. Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment
44. The role of T cell immunity in control of herpes simplex virus
45. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11
46. Growth of human cytomegalovirus in primary macrophages
47. C-terminal extension of the MHC class 11 associated invariant chain by an antigenic sequence triggers activation of naive T cells
48. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells
49. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes
50. Viral subversion of the immune system
51. Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential
52. Proteases involved in MHC class II antigen presentation
53. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol
54. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
55. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens
56. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: Importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes
57. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes